VELA DIAGNOSTICS

History

Year	Detail
2011	The company was established.
2012	Establishment of PCR workflows and first CE-IVD tests.
2013	Start of direct sales in Australia and Malaysia.
2014	Launch of the NGS-based oncology panel for IVD use in Europe and Asia.
2015	Investment and collaboration agreement with Luye Group Ltd.
2016	Acquisition of Lifecode Inc.’s data interpretation assets.
2018	Acquisition of Great Basin Scientific.
2020	Launch of NGS-based, Pan-Cancer OncoKey SL 60 Plus Assay.
2023	Vela Diagnostics collaborated with SRL Inc. to distribute products in Japan.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.